Cargando…
Elafin is related to immune infiltration and could predict the poor prognosis in ovarian cancer
BACKGROUND: Ovarian cancer (OC) is the most lethal gynecologic malignancy, yet the clinical results for OC patients are still variable. Therefore, we examined how elafin expression affects the patients’ prognoses and immunotherapy responses in OC, which may facilitate treatment selection and improve...
Autores principales: | Lu, Weiyu, Xie, Biao, Tan, Guangqing, Dai, Wanying, Ren, Jingyi, Pervaz, Sadaf, Li, Kun, Li, Fangfang, Wang, Yingxiong, Wang, Meijiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893492/ https://www.ncbi.nlm.nih.gov/pubmed/36742380 http://dx.doi.org/10.3389/fendo.2023.1088944 |
Ejemplares similares
-
RB1 Is an Immune-Related Prognostic Biomarker for Ovarian Cancer
por: Xie, Biao, et al.
Publicado: (2022) -
The PNA mouse may be the best animal model of polycystic ovary syndrome
por: Ren, Jingyi, et al.
Publicado: (2022) -
EIF4G1 Is a Potential Prognostic Biomarker of Breast Cancer
por: Li, Kun, et al.
Publicado: (2022) -
High Serum Elafin Prediction of Poor Prognosis of Locoregional Esophageal Squamous Cell Carcinoma
por: Wu, I-Chen, et al.
Publicado: (2021) -
Elafin: a double agent in breast and ovarian cancer
por: Feng, Yi, et al.
Publicado: (2015)